Imperial College London


Faculty of MedicineDepartment of Surgery & Cancer

Honorary Clinical Senior Lecturer







Institute of Reproductive and Developmental BiologyHammersmith Campus






BibTex format

author = {Gullam, JE and Chatterjee, J and Thornton, S},
doi = {10.1016/j.ddstr.2005.05.023},
journal = {Drug Discovery Today: Therapeutic Strategies},
pages = {47--52},
title = {Preterm labour: Novel treatments},
url = {},
volume = {2},
year = {2005}

RIS format (EndNote, RefMan)

AB - Prematurity is a major cause of perinatal death and childhood disability. The risks are increased at early gestational ages so that a delay in delivery by preventing preterm labour or inhibiting uterine contractions can improve outcome for the newborn. Here, we review the mechanism of action and clinical evidence for the renewed enthusiasm for prevention of preterm delivery in high-risk women by administration of progesterone. At present, there is also controversy regarding the optimal management of threatened preterm labour, so we outline the rationale for treatment and clinical evidence for administration of an oxytocin antagonist in acute situations. © 2005 Elsevier Ltd. All rights reserved.
AU - Gullam,JE
AU - Chatterjee,J
AU - Thornton,S
DO - 10.1016/j.ddstr.2005.05.023
EP - 52
PY - 2005///
SN - 1740-6773
SP - 47
TI - Preterm labour: Novel treatments
T2 - Drug Discovery Today: Therapeutic Strategies
UR -
VL - 2
ER -